<?xml version="1.0" encoding="UTF-8"?>
<p>Looking into potential use of 
 <italic>C. elegans</italic>, this study focused on the use of 
 <italic>Cassia siamea</italic> (yellow cassia) plant extract. 
 <italic>Cassia siamea</italic> is an evergreen medium size tree which can grow with a straight trunk to the height of 18 m and with a trunk girth of 30 cm in diameter and belongs to the family of Fabiaceae (
 <xref rid="b13-tlsr-31-3-145" ref-type="bibr">Kamagat√© 
  <italic>et al</italic>. 2014
 </xref>). The plant grows naturally in many Asian countries such as Malaysia, Brunei and China. It is extensively cultivated in afforestation programmes in many African countries (
 <xref rid="b24-tlsr-31-3-145" ref-type="bibr">Orwa 
  <italic>et al</italic>. 2009
 </xref>). 
 <italic>Cassia siamea</italic> has been reported to be a useful antioxidant, antimicrobial, antimalarial, anticancer, antihypotensive, anti-inflammatory and antidepressant (
 <xref rid="b22-tlsr-31-3-145" ref-type="bibr">Ntandou 
  <italic>et al</italic>. 2010
 </xref>). The objective of this study was to investigate the efficacy of aqueous and methanol extract of 
 <italic>C. siamea</italic> against the motility of 
 <italic>C. elegans</italic> Bristol N2 (susceptible to ivermectin) and 
 <italic>C. elegans</italic> DA1316 (ivermectin resistant strain).
</p>
